CUA2026 encourages you to submit an abstract to share your research and engage with highly specialised urologists from around the world.
Abstract Submission Guidelines
i. Language
Abstracts must be written and presented in English. Careful typing and proofreading are essential. If accepted, the abstract will be published as submitted. Errors, misspellings, incorrect hyphenation, and deviations from the use of correct English will be glaringly apparent in the published abstract. Once the abstract is submitted, changes, corrections or rewording will not be possible. Presenters are requested to devote the necessary attention to language to avoid deviations from the use of good English. The Scientific Committee reserves the right to reject abstracts which are presented in poor English or to request an immediate revision.
ii. Word Count
Abstracts must not exceed 350 words.
iii. Images, Tables and Graphs
Images, tables and graphs will not be accepted during the initial submission stage. Should your abstract be accepted, these elements can be added to your ePoster.
iv. Topic Area
To ensure that your abstract receives proper scientific consideration, be sure to submit to the appropriate topic as indicated on the submission form.
v. Abstract Title
Your abstract must have a short, specific title (no abbreviations) that indicates the nature of the investigation.
Please use title case. Example: "Complications in Laparoscopic Transperitoneal Partial Nephrectomy."
Consult Sample Abstract for additional information.
vi. Sections
Abstracts must include the following four distinct sections:
Introduction and Objectives
Materials and Methods
Results
Conclusion
vii. Drug Names
Use generic drug names.
viii. Abbreviations
Standard abbreviations may be used without definition. Nonstandard abbreviations should be kept to a minimum and placed in parentheses after the first use of the word or phrase.
ix. Acknowledgments
Do not include references, credits or grant support.
x. Human Experimentation
Any human experimentation conducted as part of the submitted abstract(s) must follow the protocol approved by the institutional or local committee on ethics in human investigation; or, if no such committee exists, the investigation should have been conducted in accordance with the principles of the World Medical Association’s Helsinki Declaration. The Scientific Committee may inquire further into ethical aspects when evaluating the abstract(s).
xi. Abstract Data
Abstracts that describe single clinical cases, or investigations of compounds that involve inadequate numbers of study subjects or abstracts that lack quantitative data will not be accepted.
Authors should not "split" data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
Abstracts containing identical or nearly identical data submitted from the same institution (and/or individuals) describing the same study population will be disqualified. Statements such as "results will be discussed" will automatically disqualify the abstract. Reviewers may require specific data on which to base their evaluation.
xii. Sample Abstract
Complications in Laparoscopic Transperitoneal Partial Nephrectomy
Introduction and Objectives: We review the complications of laparoscopic partial nephrectomy in a single surgeon series.
Materials and Methods: Between July 1999 and April 2006, a total of 125 patients underwent laparoscopic transperitoneal partial nephrectomy. Mean patient age was 58 years (range 33 to 87) and male to female ratio was 2:1. In 43 patients (34%) the procedure was hand-assisted. A database was kept prospectively for all patients.
Results: Mean operative time was 104 minutes (range 35 to 180) and average surgical bleeding was 258 ml (range 0 to 2000). For procedures with warm ischemia, mean arterial clamping time was 26 minutes (range 15 to 60). Mean tumor size was 2.7 cm (range 1 to 7). A total of 14 patients (11.2%) had one or more complications which were intraoperative 6 (4.8%) and postoperative 8 (6.4%) with two delayed complications. Intraoperative hemorrhage occurred in 6 cases (4.8%), and postoperatively in another 6 (4.8%). Intraoperative hemorrhage was managed in 2 cases with laparoscopic radical nephrectomy and in 4 cases with intracorporeal suture. Postoperative hemorrhage required reoperation in 4 patients: two open radical nephrectomies, one laparoscopic radical nephrectomy and one laparoscopic re-suture of the kidney. The remaining two patients were managed with endovascular (percutaneous) embolization. Urine leakage occurred in one case (0.8%) and was managed conservatively with a double-J stent. A digestive hemorrhage and a pulmonary embolism were presented by two patients (1.6%). Transfusion rate was 10.4%. No case required conversion to open surgery. Mean hospital stay was 3.6 days (range 1 to 12).
Conclusion: Laparoscopic transperitoneal partial nephrectomy is technically demanding with a high potential for complications. The most frequent complication is either intra- or post-operative hemorrhage. For delayed bleeding, endovascular techniques are safe and effective and thus our first choice in the stable patient.
xiii. Contact
For any questions pertaining to your abstract submission, please contact: cmacua@163.com
Contact Us
Contact: Phoebe Zhang (Ms.)
Phone：0086-16622901885
Contact: Bai (Mr.)
Phone：0086-18610887968
Email: cmacua@163.com